Tofacitinib oral sustained release dosage forms | Patent Number 10639309

US 10639309 B2
Application Number15915750
Publication NumberUS 20180193347 A1
Pendency2 years, 1 month, 29 days
Filled DateMar 8, 2018
Priority DateMar 16, 2013
Publication DateJul 12, 2018
Expiration DateMar 15, 2033
Inventor/ApplicantsSriram Krishnaswami
Manisha Lamba
Scott Max Herbig
Joseph Kushner
Thomas C. Stock
Joseph Kushner, IV
ExaminesGOTFREDSON, GAREN
Art Unit1619
Technology Center1600
Assignments
Pfizer Legal Division 2
Current
Pfizer Legal Division 2Pfizer
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.